4//SEC Filing
Riley Brigit 4
Accession 0001209191-22-019633
CIK 0001501756other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:53 PM ET
Size
5.9 KB
Accession
0001209191-22-019633
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-08+195,000→ 195,000 totalExercise: $1.29Exp: 2032-03-07→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 18, 2022 (the "Vesting Commencement Date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001882857
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:53 PM ET
- Size
- 5.9 KB